Annual Cash & Cash Equivalents
$1.61 M
-$7.50 M-82.34%
December 31, 2023
Summary
- As of February 8, 2025, PRPH annual cash & cash equivalents is $1.61 million, with the most recent change of -$7.50 million (-82.34%) on December 31, 2023.
- During the last 3 years, PRPH annual cash & cash equivalents has fallen by -$5.21 million (-76.39%).
- PRPH annual cash & cash equivalents is now -94.31% below its all-time high of $28.30 million, reached on December 31, 1998.
Performance
PRPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$501.00 K
-$1.28 M-71.85%
September 30, 2024
Summary
- As of February 8, 2025, PRPH quarterly cash and cash equivalents is $501.00 thousand, with the most recent change of -$1.28 million (-71.85%) on September 30, 2024.
- Over the past year, PRPH quarterly cash and cash equivalents has dropped by -$1.11 million (-68.86%).
- PRPH quarterly cash and cash equivalents is now -98.83% below its all-time high of $42.80 million, reached on March 31, 2017.
Performance
PRPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PRPH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -82.3% | -68.9% |
| 3 y3 years | -76.4% | -68.9% |
| 5 y5 years | +3.5% | -95.4% |
PRPH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.3% | at low | -98.1% | at low |
| 5 y | 5-year | -82.3% | +270.7% | -98.5% | +15.4% |
| alltime | all time | -94.3% | +302.3% | -98.8% | +33.6% |
ProPhase Labs Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $501.00 K(-71.9%) |
| Jun 2024 | - | $1.78 M(+51.5%) |
| Mar 2024 | - | $1.18 M(-27.0%) |
| Dec 2023 | $1.61 M(-82.3%) | $1.61 M(+129.2%) |
| Sep 2023 | - | $702.00 K(-81.6%) |
| Jun 2023 | - | $3.82 M(-60.2%) |
| Mar 2023 | - | $9.61 M(+5.5%) |
| Dec 2022 | $9.11 M(+8.3%) | $9.11 M(-60.0%) |
| Sep 2022 | - | $22.80 M(-4.8%) |
| Jun 2022 | - | $23.96 M(-7.2%) |
| Mar 2022 | - | $25.81 M(+206.9%) |
| Dec 2021 | $8.41 M(+23.4%) | $8.41 M(-1.5%) |
| Sep 2021 | - | $8.53 M(-51.7%) |
| Jun 2021 | - | $17.68 M(-46.0%) |
| Mar 2021 | - | $32.73 M(+380.1%) |
| Dec 2020 | $6.82 M(+1470.5%) | $6.82 M(-37.2%) |
| Sep 2020 | - | $10.86 M(+328.1%) |
| Jun 2020 | - | $2.54 M(+264.0%) |
| Mar 2020 | - | $697.00 K(+60.6%) |
| Dec 2019 | $434.00 K(-72.1%) | $434.00 K(-55.2%) |
| Sep 2019 | - | $968.00 K(-7.7%) |
| Jun 2019 | - | $1.05 M(-57.2%) |
| Mar 2019 | - | $2.45 M(+57.7%) |
| Dec 2018 | $1.55 M(-51.0%) | $1.55 M(-31.5%) |
| Sep 2018 | - | $2.27 M(-38.1%) |
| Jun 2018 | - | $3.67 M(+8.2%) |
| Mar 2018 | - | $3.39 M(+6.7%) |
| Dec 2017 | $3.17 M(+619.5%) | $3.17 M(-18.6%) |
| Sep 2017 | - | $3.90 M(-89.5%) |
| Jun 2017 | - | $37.28 M(-12.9%) |
| Mar 2017 | - | $42.80 M(+9605.2%) |
| Dec 2016 | $441.00 K(-73.5%) | $441.00 K(+17.6%) |
| Sep 2016 | - | $375.00 K(-67.4%) |
| Jun 2016 | - | $1.15 M(-53.2%) |
| Mar 2016 | - | $2.46 M(+47.7%) |
| Dec 2015 | $1.66 M(-43.1%) | $1.66 M(+24.6%) |
| Sep 2015 | - | $1.34 M(-64.5%) |
| Jun 2015 | - | $3.76 M(-25.1%) |
| Mar 2015 | - | $5.02 M(+71.6%) |
| Dec 2014 | $2.93 M(+78.6%) | $2.93 M(-40.9%) |
| Sep 2014 | - | $4.95 M(-32.6%) |
| Jun 2014 | - | $7.35 M(+33.2%) |
| Mar 2014 | - | $5.52 M(+236.9%) |
| Dec 2013 | $1.64 M(+186.4%) | $1.64 M(+118.1%) |
| Sep 2013 | - | $751.00 K(-81.5%) |
| Jun 2013 | - | $4.06 M(-10.5%) |
| Mar 2013 | - | $4.54 M(+693.0%) |
| Dec 2012 | $572.00 K(-89.7%) | $572.00 K(-68.5%) |
| Sep 2012 | - | $1.81 M(-60.6%) |
| Jun 2012 | - | $4.61 M(-26.5%) |
| Mar 2012 | - | $6.27 M(+13.1%) |
| Dec 2011 | $5.54 M(-32.7%) | $5.54 M(+20.0%) |
| Sep 2011 | - | $4.62 M(-47.2%) |
| Jun 2011 | - | $8.74 M(-8.8%) |
| Mar 2011 | - | $9.59 M(+16.4%) |
| Dec 2010 | $8.23 M | $8.23 M(-5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $8.71 M(-22.0%) |
| Jun 2010 | - | $11.16 M(-9.6%) |
| Mar 2010 | - | $12.35 M(-3.5%) |
| Dec 2009 | $12.80 M(+7.1%) | $12.80 M(+43.1%) |
| Sep 2009 | - | $8.95 M(-2.9%) |
| Jun 2009 | - | $9.22 M(-24.7%) |
| Mar 2009 | - | $12.24 M(+2.4%) |
| Dec 2008 | $11.96 M(-21.0%) | $11.96 M(+9.9%) |
| Sep 2008 | - | $10.88 M(-24.3%) |
| Jun 2008 | - | $14.38 M(-11.6%) |
| Mar 2008 | - | $16.27 M(+7.5%) |
| Dec 2007 | $15.13 M(-14.8%) | $15.13 M(+21.2%) |
| Sep 2007 | - | $12.48 M(-21.2%) |
| Jun 2007 | - | $15.84 M(-17.4%) |
| Mar 2007 | - | $19.18 M(+8.0%) |
| Dec 2006 | $17.76 M(+5.2%) | $17.76 M(+30.6%) |
| Sep 2006 | - | $13.60 M(-15.3%) |
| Jun 2006 | - | $16.06 M(-11.7%) |
| Mar 2006 | - | $18.19 M(+7.7%) |
| Dec 2005 | $16.89 M(+17.5%) | $16.89 M(+38.7%) |
| Sep 2005 | - | $12.17 M(-12.9%) |
| Jun 2005 | - | $13.98 M(-15.2%) |
| Mar 2005 | - | $16.48 M(+14.7%) |
| Dec 2004 | $14.37 M(+26.1%) | $14.37 M(+22.8%) |
| Sep 2004 | - | $11.70 M(-14.8%) |
| Jun 2004 | - | $13.74 M(-11.9%) |
| Mar 2004 | - | $15.59 M(+36.8%) |
| Dec 2003 | $11.39 M(-11.7%) | $11.39 M(+7.0%) |
| Sep 2003 | - | $10.65 M(-14.0%) |
| Jun 2003 | - | $12.38 M(-7.0%) |
| Mar 2003 | - | $13.31 M(+3.2%) |
| Dec 2002 | $12.90 M(+33.2%) | $12.90 M(+14.2%) |
| Sep 2002 | - | $11.29 M(-12.0%) |
| Jun 2002 | - | $12.84 M(+19.4%) |
| Mar 2002 | - | $10.75 M(+11.0%) |
| Dec 2001 | $9.68 M(-14.8%) | $9.68 M(+27.7%) |
| Sep 2001 | - | $7.59 M(-12.8%) |
| Jun 2001 | - | $8.70 M(-10.4%) |
| Mar 2001 | - | $9.71 M(-14.6%) |
| Dec 2000 | $11.37 M(-18.8%) | $11.37 M(+12.5%) |
| Sep 2000 | - | $10.11 M(+23.0%) |
| Jun 2000 | - | $8.21 M(-32.1%) |
| Mar 2000 | - | $12.11 M(-13.5%) |
| Dec 1999 | $14.00 M(-50.5%) | $14.00 M(+4.5%) |
| Sep 1999 | - | $13.40 M(-8.8%) |
| Jun 1999 | - | $14.70 M(-38.0%) |
| Mar 1999 | - | $23.70 M(-16.3%) |
| Dec 1998 | $28.30 M(+11.0%) | $28.30 M(+6.0%) |
| Sep 1998 | - | $26.70 M(-7.6%) |
| Jun 1998 | - | $28.90 M(-10.5%) |
| Mar 1998 | - | $32.30 M(+26.7%) |
| Dec 1997 | $25.50 M(+6275.0%) | $25.50 M(+231.2%) |
| Sep 1997 | - | $7.70 M(+16.7%) |
| Jun 1997 | - | $6.60 M(-26.7%) |
| Mar 1997 | - | $9.00 M |
| Dec 1996 | $400.00 K | - |
FAQ
- What is ProPhase Labs annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ProPhase Labs?
- What is ProPhase Labs annual cash & cash equivalents year-on-year change?
- What is ProPhase Labs quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ProPhase Labs?
- What is ProPhase Labs quarterly cash and cash equivalents year-on-year change?
What is ProPhase Labs annual cash & cash equivalents?
The current annual cash & cash equivalents of PRPH is $1.61 M
What is the all time high annual cash & cash equivalents for ProPhase Labs?
ProPhase Labs all-time high annual cash & cash equivalents is $28.30 M
What is ProPhase Labs annual cash & cash equivalents year-on-year change?
Over the past year, PRPH annual cash & cash equivalents has changed by -$7.50 M (-82.34%)
What is ProPhase Labs quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PRPH is $501.00 K
What is the all time high quarterly cash and cash equivalents for ProPhase Labs?
ProPhase Labs all-time high quarterly cash and cash equivalents is $42.80 M
What is ProPhase Labs quarterly cash and cash equivalents year-on-year change?
Over the past year, PRPH quarterly cash and cash equivalents has changed by -$1.11 M (-68.86%)